Clinical Trials Directory

Trials / Completed

CompletedNCT04726280

Respiratory Impact of LA Volume After IS Block

Respiratory Impact of Local Anaesthetic Volume for an Interscalene Brachial Plexus Block With an Extrafascial Approach.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Eric Albrecht · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of this study is that a reduced extrafascial volume of local anesthetic for an interscalene brachial plexus block is associated with a lower incidence of diaphragmatic hemiparalysis after an arthroscopic surgery of the shoulder, without any reduction of the analgesic efficacy.

Detailed description

The hypothesis of this study is that a reduced extrafascial volume of local anesthetic for an interscalene brachial plexus block is associated with a lower incidence of diaphragmatic hemiparalysis after an arthroscopic surgery of the shoulder, without any reduction of the analgesic efficacy. Our prospective randomized controlled trial will include two parallel groups: a group will receive a volume of 20 mls of ropivacaine 0.75%, while the other group will receive a volume of 10 mls. All participants will have a preoperative ultrasound-guided interscalene brachial plexus with an extrafascial injection of 10 or 20 mls of ropivacaine 0.75%. In both groups, participants will have an examination of the hemidiaphgragm with the ultrasound, before and 30 min after the block. The respiratory function will also be assessed with a bedside spirometer before and after the block, and at 12 and 24 postoperative hours. During surgery all participants will receive multimodal analgesia inclusive of iv dexamethasone 8 mg, iv magnesium sulfate 40 milligram kg\^2, iv ketorolac 30 milligrams, and iv acetaminophen 1000 milligrams, according to the current practice in our institution. In the postoperative period, Participants will be prescribed an IV pca of morphine. Assignment to one of these two groups will be done according to a computer-generated list of random numbers, and the sealed envelopes method will be used.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine 0.75% Injectable Solution10 ml extrafascial interscalene brachial plexus block
DRUGRopivacaine 0.75% Injectable Solution20 ml extrafascial interscalene brachial plexus block

Timeline

Start date
2021-02-01
Primary completion
2023-11-20
Completion
2023-11-20
First posted
2021-01-27
Last updated
2023-11-21

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04726280. Inclusion in this directory is not an endorsement.